Monthly Income Updates – August and September 2024
-
Dear Readers, I am back with yet another monthly income update post.
Devoting time to blogging has been a challenge with work and time with
family taking p...
Johnson & Johnson (JNJ) Dividend Stock Analysis
-
Linked here is a detailed quantitative analysis of Johnson & Johnson (JNJ).
Below are some highlights from the above linked analysis: Company
Description: ...
Warren Buffett and Strategy Diversification
-
Many investors discuss Buffett on diversification, and conclude that he ran
a "concentrated portfolio"
This is missing the nuance that he was diversified...
Undervalued Dividend Kings: October 2024
-
Dividend Kings are exceptional dividend companies that have increased
their annual dividend payouts for 50 or more consecutive years. This
achievement is ...
October 2024 Net Worth $2,054,424
-
Hey Everyone and welcome to our October 2024 net worth update. We’re at
$2.054 million, up over $22k in what was another great month for our
investments....
2022 Week 46 investing and trading report
-
I feel like the markets are easing their bearish stance. They are still
extremely volatile and choppy intraday, but we are poised for a rally that
may la...
2020 Q1 Dividends - $430.58
-
The markets have been in turmoil and I have seen my investments drop by
20%. My standard reply to market volatility has been that I don’t care
because I ...
Portfolio Update – March 2021 – $1,000 per month!
-
I am a little shocked, and disappointed in myself, that it has been almost
eight months since my last post. The timing makes sense though: I went back
to s...
Passive Income for July 2020
-
Once a month, I like to talk about my total passive income for the previous
month. I do this to track how much passive income is coming in. When I
start ...
Portfolio Update May 2020
-
It is time to give a new update about my current portfolio. April has shown
some recovery of my portfolio and also of my dividend …
The post Portfolio Up...
Cardiovascular Systems
-
Cardiovascular Systems, Inc., a medical technology company, develops,
manufactures, and markets devices to treat vascular diseases in the United
States. Th...
Buy: ABBV
-
Today I added a new position: ABBV. They didn't show up on my screener
because some spin-off activity made it look like their div history is much
shorter t...
Philip Morris International (PM) appears to be a solid international play, operating in the somewhat murky waters of the tobacco industry. I say murky because although tobacco laws are not as stringent outside the U.S. and lawsuits are not as omnipresent, you always have to be careful investing in an industry where the product the company sells causes health problems to the people buying said product. That being said, this is a very profitable business, and if investing in tobacco companies doesn't go against your moral code, I think this is a solid play.
Philip Morris International is the world's second-largest tobacco company, behind only China National Tobacco, and holds almost 16% of the non-U.S. market. The firm owns seven of the leading 15 international brands, including Marlboro, the company's flagship brand that accounted for more than one third of total volume in 2010. Other key brands include L&M, Philip Morris, Bond Street, Chesterfield, Parliament, and Lark.
Owning almost half of the leading international brands in any product segment is appealing, coming from an investor standpoint. This, to me, is no different with tobacco. There appears to be significant brand loyalty with cigarettes, so this bodes well for Philip Morris. Owning almost half of the leading international brands gives Philip Morris an enviable spot, and I would say it has an economic moat due to its brand loyalty, economy of scale on a global footprint and the fact that the products it sells are addictive.
Let's take a look at some numbers.
I can't include numbers as far back as some of the companies I look at because Philip Morris was spun off from Altria (MO) in 2008. The numbers I'm posting are from 2008-forward.
Earnings per share has grown at a rate of 8.7%, compounded annually, over the last two years. Obviously, two years is a short time frame to try and analyze a company, but this company was part of Altria for many years so it's hitting the ground running. This isn't your local start-up.
Revenue has grown by a rate of 2.9%, compounded annually. This is a lower number than I expected, but I think this number will be close to double digits going forward. The growth from 2009-2010 was almost 9%, and analysts expect revenue to grow by 11% this year.
As always, dividend growth is my favorite metric to inspect. This is where Philip Morris shines, and probably will continue to shine as time goes on. This isn't a dividend growth stock if you consider that most investors need at least five years of growth to invest, and some need ten. I feel that having a long history as part of Altria gives it the benefit of the doubt here. Dividends have grown by 25.87%, compounded annually over the last 2 years. Huge growth here, but this is largely skewed by the fact that 2008 only had 3 dividends paid due to the split that year from Altria. The 1-year growth from 2009-2010 was 8.93%, which is certainly a realistic figure going forward. The entry yield as of this writing is 3.88%, which is attractive, but not as attractive as some other tobacco stocks. I like the international growth prospects as they rank either #1 or #2 in the top 3 cigarette markets in the world (except the U.S. and China). I'll sacrifice a little yield now, for growth later here. The payout ratio is 63%, which is very comfortable and even perhaps a little low for a tobacco company. I feel there is plenty of room for growth of the dividend.
Dividends Per Year($ Per Share) 20102.44 20092.24 20081.54
Overall, I'm a buyer of Philip Morris at current prices. I think it's attractively valued with a current P/E ratio of 16.19. That's a great valuation for a company with a strong yield, excellent growth prospects, a great product lineup and let's not forget the product is addictive.
S&P has Philip Morris at a 5-star STRONG BUY. I generally agree with that.
The stock did recently touch a lifetime high at $71.75 and has since scaled back to the mid-$60's. I would like to be patient with this stock and see if it scales back even further, perhaps to the high $50's. At any rate, I like it at it's current price and would consider adding to my position.
Disclosure: I am long PM.
Thanks for reading.
This article was written by Dividend Mantra. If you enjoyed this article, please consider subscribing to my feed.
Many investors discuss Buffett on diversification, and conclude that he ran
a "concentrated portfolio"
This is missing the nuance that he was diversified...
3 days ago
_________________________________________________________
Linked here is a detailed quantitative analysis of Microsoft Corporation
(MSFT). Below are some highlights from the above linked analysis: Company
Descript...
1 year ago
_________________________________________________________
Comments
Subscribe or Visit Member Sites
RSS: Dividends4Life ....................................................................... RSS:Dividend Growth Investor ....................................................................... RSS: The DIV-Net Site ....................................................................... Associate Members Sites and Feeds .......................................................................